Similar articles

• Antifibrinolytic therapy reduces blood loss in knee replacement surgery.

  Innerhofer P, Kühbacher G, Schobersberger W. Innerhofer P, et al. Anesth Analg. 2000 Aug;91(2):497-8. doi: 10.1097/00000539-200008000-00061. Anesth Analg. 2000. PMID: 10910882 No abstract available.
• A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement.

  Zohar E, Fredman B, Ellis M, Luban I, Stern A, Jedeikin R. Zohar E, et al. Anesth Analg. 1999 Dec;89(6):1382-7. doi: 10.1097/00000539-199912000-00010. Anesth Analg. 1999. PMID: 10589612 Clinical Trial.
• Effectiveness and safety of tranexamic acid in total joint arthroplasty.

  Yaghmour KM, Atkinson S, Chisari E, McDonnell SM, Khan W. Yaghmour KM, et al. J Perioper Pract. 2019 Nov;29(11):356-360. doi: 10.1177/1750458919825812. Epub 2019 Jan 16. J Perioper Pract. 2019. PMID: 30650055 Review. No abstract available.
• Letter to the Editor on "Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value".

  Prakash J. Prakash J. J Arthroplasty. 2016 May;31(5):1128. doi: 10.1016/j.arth.2015.12.035. Epub 2016 Mar 3. J Arthroplasty. 2016. PMID: 27004679 No abstract available.
• Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.

  Watts CD, Pagnano MW. Watts CD, et al. J Bone Joint Surg Br. 2012 Nov;94(11 Suppl A):8-10. doi: 10.1302/0301-620X.94B11.30618. J Bone Joint Surg Br. 2012. PMID: 23118371 Review.